Medication info
Decartan Tablet 16 mg (Candesartan Cilexetil)

Decartan Tablet 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
Light yellowish-pink, round, biconvex tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201904230 · Approved 2019.06.18 · Insurance code 644004230

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time every day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is reached within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful monitoring in patients at increased risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure 3) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular systolic function impairment
  • reduced left ventricular ejection fraction
View approved original text

This medication is used for patients with essential hypertension and heart failure with reduced left ventricular function. It is especially applied to patients who require additional treatment with ACE inhibitors or who have poor tolerance. This helps to reduce the burden on the heart and improve symptoms, thus enhancing the quality of life.

How to take

Adult dose

This medicine should be taken at the same time every day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is reached within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful monitoring in patients at increased risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure 3) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Precautions

This drug can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used by those who are allergic to this drug or its components, pregnant or breastfeeding women, patients with severe liver disease, those with a history of certain angioedema, and patients with specific genetic diseases. Elderly patients, patients with hyperkalemia, liver disease, or heart and kidney diseases should exercise extra caution when using this drug, and regular monitoring of kidney function and blood pressure is necessary. Some patients may experience mild side effects such as dizziness, back pain, or respiratory infections, while heart failure patients may experience hypotension, hyperkalemia, or kidney function impairment, making it crucial to regularly check their conditions through blood tests. Rare side effects such as blood and lymphatic system abnormalities, liver dysfunction, skin rash, muscle pain, and hematuria have also been reported, so any unusual symptoms should prompt immediate consultation with medical personnel. This drug can enhance the effects of other antihypertensive medications, so consult with your doctor before using it. Special caution is needed when combined with lithium or potassium-sparing diuretics to carefully monitor serum potassium levels. Women of childbearing potential should confirm their pregnancy status before taking this drug, and breastfeeding women should avoid its use. In case of overdose, symptoms such as hypotension, dizziness, and tachycardia may occur, necessitating immediate medical attention. Safety in children and adolescents has not been established, so its use is not recommended. Finally, this drug should be stored out of the reach of children and should not be transferred to other containers.

Side effects

  • Dizziness
  • low back pain
  • respiratory infection
  • upper respiratory tract infection
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 66 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • weakness
  • fever
  • sensory abnormalities
  • indigestion
  • gastritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hypokalemia
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzymes
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • kidney dysfunction
  • acute kidney failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorders
  • decreased libido
  • amnesia
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste distortion
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it is best kept at room temperature between 1 to 30 degrees Celsius. Avoid extremely hot or cold environments.

Appearance and packaging

Appearance

Light yellowish-pink, round, biconvex tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.